Emory University
Atlanta, Georgia, 30322, United States
NCT Number: NCT04219878
This study will use online materials and strategies to recruit 3600 Black and Hispanic men who have sex with men (MSM) and transgender women (TGW) to participate in a study evaluating the effectiveness of the Know@Home mobile app compared to control condition with respect to linkage of participants to appropriate services, as well as cost-effectiveness outcomes.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Atlanta, Georgia, 30322, United States
To evaluate the effectiveness of mailing out rapid HIV home-testing kits and additional testing promotion components among African-American or black and Hispanic or Latino gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW), the study "Implementation of Rapid HIV Self-Testing among MSM Project", known as iSTAMP, is being conducted in 11 US states. This study is interested in the most cost-effective ways to recruit people at high risk for HIV infection. The researchers want to study a sample of 3600 adult MSM and TGW who are not known to be living with HIV; 1800 black/African-American and 1800 Hispanic/Latino participants will be enrolled.
All participants will be mailed two rapid HIV self-test kits upon randomization. All participants, regardless of study arm, will also complete a follow-up survey at the end of a 4-month follow-up period. At the end of the 4-month follow-up period, participants will be mailed a dried blood spot (DBS) collection kit for research purposes, as well as another rapid HIV self-test kit for immediate testing. Participants in each of the arms will have access to videoconferencing-delivered prevention counseling, and all participants, regardless of assigned arm, will be contacted if they report seroconversion and/or a preliminary positive test during the study period for active linkage to care.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for MSM Participants:
Exclusion criteria
for MSM Participants:
Inclusion criteria
for TGW:
Exclusion criteria
for TGW:
Participants randomly assigned to the Know@Home arm will access the features of Know@Home by downloading the app or accessing the website. The contents were developed to serve as a comprehensive mobile HIV prevention platform for MSM or TGW, with HIV prevention and care information and links to resources. This intervention arm provides an toolkit that allows users to access information about prevention services as their needs change. Participants will have access to Know@Home for the study period. The Know@Home arm will offer participants the opportunity to order free condoms and lubricant as well as an at-home sexually transmitted infection (STI) testing kit.
All participants will be shipped two at-home HIV self-tests. They will also receive a link to a previously-produced video that fully describes the specimen collection process, pointing out common errors and providing tips for successful collection. Participants will interact with study staff through phone, email, or text. Information to schedule a video HIV testing and counseling session with study staff will be made available to participants in all arms via a website, email, and/or text.
Other names: OraQuick® In-Home HIV Test
Time frame: Up to Month 4
Effectiveness of the interventions will be assessed by linkage of participants to HIV treatment.
Time frame: Up to Month 4
Effectiveness of the interventions will be assessed by linkage of participants to PrEP treatment.
Time frame: Up to Month 4
Effectiveness of the interventions will be assessed by linkage of participants to STI testing.
Time frame: Up to Month 4
Effectiveness of the interventions will be assessed by linkage of participants to HIV prevention services.
Time frame: Up to Month 4
Effectiveness of the interventions will be assessed by linkage of participants to HIV social services.
Time frame: Baseline
Enrollment in the study defined as completion of the baseline survey and downloading of the study app. The cost (in US dollars) to enroll participants (online banner advertisement placement, study staff time to manage enrollment, validating participant eligibility, monitoring and evaluation of enrollment data) will be compared between the study arms.
Time frame: Month 1
The cost (in US dollars) of HIV tests returned within 1 month of enrollment will be compared between the study arms. The costs involved with having HIV tests returned include:
Time frame: Month 1
The cost (in US dollars) of identifying established HIV infections will be compared between the study arms. The costs involved with identifying established HIV infections include:
Time frame: Month 4
The cost (in US dollars) of linking participants testing positive for HIV to HIV counseling will be compared between the study arms, including:
Time frame: Month 4
The cost (in US dollars) of linking participants testing positive for HIV to HIV treatment will be compared between the three study arms, including:
Time frame: Month 4
The cost (in US dollars) of linking participants testing negative for HIV to PrEP counseling will be compared between the study arms, including:
Time frame: Month 4
The cost (in US dollars) of linking participants testing negative for HIV to initiate PrEP treatment will be compared between the study arms, including:
Time frame: Month 4
The cost (in US dollars) of providing at-home STI testing be compared between the study arms, including:
Time frame: Month 4
The cost (in US dollars) of providing treatment for STIs discovered through at-home STI testing be compared between the three study arms, including:
Emory University
Other
Engaging African American and Hispanic/Latino MSM for HIV Testing and Prevention Services Through Technology
Acronym: iSTAMP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04446611
Acquired Immunodeficiency Syndrome, Antenatal Care
East London, Eastern Cape, South Africa
View Trial DetailsNCT06952582
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Metu, Oromiya, Ethiopia
View Trial DetailsNCT04710784
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Yaba, Lagos, Nigeria
View Trial DetailsNCT04050540
Acquired Immunodeficiency Syndrome, Bacterial Infections
Kisumu, Kenya
View Trial Details